Cargando…

Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis

Recently, modified fibrosis-4 index (mFIB-4) and the easy liver fibrosis test (eLIFT) were developed for predicting liver fibrosis in chronic liver disease patients. We evaluated whether the 2 tests can predict hepatocellular carcinoma (HCC) risk in alcoholic liver cirrhosis (ALC) patients. A retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Hyun, Lee, Minjong, Park, Seung Woo, Kang, Myungho, Kim, Minjeong, Lee, Sang Hoon, Kim, Tae Suk, Park, Jin Myung, Choi, Dae Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283079/ https://www.ncbi.nlm.nih.gov/pubmed/30508959 http://dx.doi.org/10.1097/MD.0000000000013438

Ejemplares similares

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
por: Shin, Sangdeok, et al.
Publicado: (2020)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
por: Kim, Ji Hyun, et al.
Publicado: (2020)

Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis
por: Bang, Chang Seok, et al.
Publicado: (2016)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
por: Lee, Junggyu, et al.
Publicado: (2015)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022)

Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
por: Cha, Jung Hoon, et al.
Publicado: (2013)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Hepatopulmonary Syndrome in Poorly Compensated Postnecrotic Liver Cirrhosis by Hepatitis B Virus in Korea
por: Lee, Jae Ho, et al.
Publicado: (2001)

A Novel Model to Predict Esophageal Varices in Patients with Compensated Cirrhosis Using Acoustic Radiation Force Impulse Elastography
por: Park, Yehyun, et al.
Publicado: (2015)

CLIF–SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis
por: Jeong, Jin Hee, et al.
Publicado: (2016)

Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis
por: Kwon, Ji Hye, et al.
Publicado: (2021)

A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis
por: Lee, Kyunghan, et al.
Publicado: (2022)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Association between interstitial cells of Cajal and anti-vinculin antibody in human stomach
por: Kim, Ji Hyun, et al.
Publicado: (2020)

Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
por: Lim, Ji Young, et al.
Publicado: (2020)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
por: Kim, Ji Hyun, et al.
Publicado: (2022)

Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
por: Kim, Tae Suk, et al.
Publicado: (2021)

Effect of Chronic Alcohol Ingestion on Bone Mineral Density in Males without Liver Cirrhosis
por: Kim, Mi Jin, et al.
Publicado: (2003)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
por: Kim, Mo-Jong, et al.
Publicado: (2023)

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
por: Albhaisi, Somaya, et al.
Publicado: (2023)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding
por: Kim, Sung Eun, et al.
Publicado: (2017)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling
por: Jun, Ji Hye, et al.
Publicado: (2021)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
por: Kim, Minah, et al.
Publicado: (2021)

Circulating granulocyte lifespan in compensated alcohol‐related cirrhosis: a pilot study
por: Potts, Jonathan R., et al.
Publicado: (2016)

Helicobacter pylori Infection and Peptic Ulcer Disease in Patients with Liver Cirrhosis
por: Kim, Dong Joon, et al.
Publicado: (2008)

Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
por: Chun, Ho Soo, et al.
Publicado: (2021)

Compensated liver cirrhosis: Natural course and disease-modifying strategies
por: Kumar, Ramesh, et al.
Publicado: (2023)

Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022)

Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease
por: Lee, Han Ah, et al.
Publicado: (2023)

Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis
por: Yu, Su Jong, et al.
Publicado: (2017)

Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
por: Yong, Seung Hyun, et al.
Publicado: (2020)

Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis
por: Marasco, Giovanni, et al.
Publicado: (2022)

The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index
por: Park, Hyo Eun, et al.
Publicado: (2020)

Hypertrophic obstructive cardiomyopathy with infundibular stenosis treated by alcohol ablation therapy.
por: Park, Sung Hak, et al.
Publicado: (2003)

Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hsqe36u4i65j8hqu4ni4oanivp